Neoplasia · 2006 · 186 citations · 19 references
Life SciencesGeneticsOncologyCancer GeneticsGenomicsMolecular OncologyCancer CytogeneticsCancer GenomicsChromosomal TranslocationsGene Fusions In CancerGenome RearrangementProstate CancerChromosome RearrangementsDna In Situ HybridizationFusion Gene DetectionGenomic Rearrangement AnalysisGenomic Rearrangement DetectionGenomic RearrangementsOncogene RearrangementsTranslocations
The recent description of novel recurrent gene fusions in approximately 80% of prostate cancer (PCa) cases has generated increased interest in the search for new translocations in other epithelial cancers and emphasizes the importance of understanding the origins and biologic implications of these genomic rearrangements. Analysis of 15 PCa cases by reverse transcription-polymerase chain reaction was used to detect six ERG-related gene fusion transcripts with TMPRSS2. No TMPRSS2/ETV1 chimeric fusion was detected in this series. Three-color fluorescence in situ hybridization confirms that TMPRSS2/ERG fusion may be accompanied by a small hemizygous sequence deletion on chromosome 21 between ERG and TMPRSS2 genes. Analysis of genomic architecture in the region of genomic rearrangement suggests that tracts of microhomology could facilitate TMPRSS2/ERG fusion events.
19
Ahmedin Jemal, Thomas S. Murray, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2005 · 5.5K citations · Full text
Recurrent Fusion of <i>TMPRSS2</i> and ETS Transcription Factor Genes in Prostate Cancer
Scott A. Tomlins, Daniel R. Rhodes, Sven Perner et al. · Science · 2005 · 3.9K citations
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Daniel R. Rhodes, Jianjun Yu, K. Shanker et al. · Neoplasia · 2004 · 3.7K citations · Full text
<i>TMPRSS2:ETV4</i> Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Scott A. Tomlins, Rohit Mehra, Daniel R. Rhodes et al. · Cancer Research · 2006 · 465 citations · Full text